Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Djibouti .
Press releases published on October 14, 2025
CodexField Officially Announces Its RWA Framework: Turning Content into Verifiable, Measurable, and Rewardable Real-World Assets
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CodexField officially announced the launch of its Real-World Asset (RWA) framework for digital content and AI models — a groundbreaking initiative designed to transform creative output into verifiable, …
CodexField Surges to the Top of Global Charts, Signaling Momentum in the Content Assetization Sector
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- In an era where generative AI is fueling an explosion of digital content, the question of how to give these creations true economic value has become central to the industry’s evolution. CodexField is addressing …
CodexField Officially Announces Its Token Framework: Powering the Next Phase of Content and Model Financialization
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CodexField officially unveiled its comprehensive token framework, marking a major step in the evolution from the creator economy to full-scale model financialization. The newly announced structure defines how …
Broadcom Introduces Industry’s First Wi-Fi 8 Silicon Ecosystem Powering the AI Era
PARIS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Broadcom Inc. (NASDAQ: AVGO) today announced the industry’s first Wi-Fi 8 silicon solutions for the broadband wireless edge ecosystem including residential gateways, enterprise access points, and smart mobile …
Peer Reviewed Publication Provides Evidence for Iron Dysregulation as a Driver of Dry AMD/GA and the Potential of Transferrin to Restore Iron Balance, Reinforcing PulseSight’s Therapeutic Strategy for PST-611
PARIS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- PulseSight Therapeutics, a clinical stage ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology welcomes the publication of new data …
CancerVax Precision Therapy Successfully Avoids Healthy Liver Cells
Lehi, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah, October 14, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that recent in-vitro studies …
Mureka Unveils Music Agent Studio and Enhanced API Capabilities, Bringing Professional Music Creation to Everyone
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Mureka, a global leader in AI music creation, announced the launch of Music Agent Studio alongside significant API enhancements, making professional music creation accessible to everyone. The dual release …
Fanttik Teams Up With Houston Rockets as an Official Partner
HOUSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Fanttik, a leading innovator in high-performance, portable power tools, today announced a partnership with the NBA’s Houston Rockets, naming Fanttik an Official Partner of the franchise. The collaboration will …
AB Science will hold a virtual conference on Thursday, October 16, 2025 from 2pm to 3pm CET to provide an update on the Phase 1 study with AB8939
PRESS RELEASE AB SCIENCE RELEASES INITIAL DATA ON THE COMBINATION OF AB8939 WITH VENETOCLAX FOR THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA (AML): THE FIRST THREE PATIENTS, ALL OF WHOM HAVE AML WITH VERY UNFAVORABLE GENETIC PROFILES, ARE …
AB Science tiendra une conférence virtuelle le jeudi 16 octobre 2025, de 14 h à 15 h CET, afin de faire le point sur l'étude de phase 1 avec AB8939
COMMUNIQUE DE PRESSE AB SCIENCE COMMUNIQUE LES PREMIERES DONNÉES DE COMBINAISON DE AB8939 AVEC VENETOCLAX : LES TROIS PREMIERS PATIENTS ATTEINTS D’UNE LEUCEMIE MYEOLIDE AIGUES (LMA) ASSOCIES A UN PROFIL GENETIQUE TRES DEFAVORABLE ET REFRACTAIRE OU EN …
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides an update on its commercial and operational performance for the quarter ended 30 September 2025 (Q3 2025 …
Helvetic Broker Launches on App Store and Play Store to Make Crypto Management Safe and Simple
Lausanne, Switzerland , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Helvetic Broker, an AI-powered self-custody crypto application, has become available on the App Store and Play Store. A team of Swiss engineers has been building the app since 2023 to democratize …
WISeKey Announces 9M 2025 Preliminary Revenue and Key Financial Metrics
WISeKey Announces 9M 2025 Preliminary Revenue and Key Financial Metrics Reports preliminary unaudited 9M 2025 revenue of $10.6 million, +39% year on year growth Reaffirms its FY 2025 Revenue Guidance of $18 to $21.0 Million, Representing a 51%–76% Year-on- …
Digital Check Introduces Next-Generation TellerScan® TS250 UV Ultraviolet Scanner
NORTHBROOK, Ill., Oct. 14, 2025 (GLOBE NEWSWIRE) -- The TellerScan TS250 UV is the latest in ultraviolet image capture from Digital Check Corp., a high-speed UV cheque scanner that succeeds the company’s best-selling TellerScan TS240 model. The new TS250 …
Adlai Nortye to Present Short Talk at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, …
DataGlobal Hub Announces Exclusive Elite Membership for Senior Data and AI Leaders
PHOENIX, Oct. 13, 2025 (GLOBE NEWSWIRE) -- DataGlobal Hub, a global media company dedicated to Data and Artificial Intelligence(AI) news, information and resources with a clear vision of creating the most prestigious and trusted network of AI professionals …
Apollomics, Inc. Company Operational Continuity Update
FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), today announced the following company operational update. Apollomics is a clinical-stage biotechnology company advancing innovative …
Spyre Therapeutics Announces Pricing of $275.0 Million Public Offering of Common Stock
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic …